argyrotsipi/train-dataset huggingface dataset:
Smoking — House of Commons, 2017-11-14
Topic: Health
Robert John Blackman (Conservative, Centre-right): I thank my hon. Friend for that answer. Does he agree that one of the most effective ways of helping people to give up smoking is the provision of smoking cessation services? In Harrow, the local unit managed to help 4,000 people attempt to give up smoking, with more than 50% doing so, but the answer from the local council has been to close the unit—that is very ineffective. Will he take action to make sure that this does not happen across the country?
Smoking — House of Commons, 2017-11-14
Topic: Health
Stephen Charles Brine (Conservative, Centre-right): My hon. Friend is right to raise the issue. Local authorities, not Ministers in Whitehall, are best placed to take local spending decisions, but they must be accountable for their decisions. That is why we publish information at local authority level on smoking prevalence and quit numbers, so that local decision makers can be held to account. We also offer them expert support from Public Health England. I have a strong feeling that he will continue to hold those in Harrow to account.
Smoking — House of Commons, 2017-11-14
Topic: Health
Questions: I am a reformed smoker—it was quite a battle. What proposals do Her Majesty’s Government have to enlist people like me to help other people to kick the weed? We know how to do it.
Stephen Charles Brine (Conservative, Centre-right): What an offer, Mr Speaker! Sustainability and transformation partnerships in all areas are to draw up local plans across one NHS area, including on the public health prevention agenda. I suggest that the hon. Gentleman volunteers his services to his local STP; I suspect it will take his hand off.
Innovative Treatments and Technologies — House of Commons, 2017-11-14
Topic: Health
Jacqueline Doyle-Price (Conservative, Centre-right): On 3 November, we published our response to the accelerated access review. We set out plans to give patients quicker access to life-changing treatments and to make the UK the best place in the world for industry to invest and innovate. We are delighted that Sir Andrew Witty will chair the group overseeing the accelerated access pathway, which will fast-track around five breakthrough products each year and support adoption and uptake of innovation across the NHS.
Innovative Treatments and Technologies — House of Commons, 2017-11-14
Topic: Health
Colin James Clark (Conservative, Centre-right): The technologies used at the neonatal unit at Aberdeen Royal Infirmary are now considered essential by my constituents in Gordon. The unit serves 500,000 people who live within 90 minutes of Aberdeen. What assessment has the Minister made of the importance of proximity of medical innovations to regional communities?
Innovative Treatments and Technologies — House of Commons, 2017-11-14
Topic: Health
Jacqueline Doyle-Price (Conservative, Centre-right): I am pleased to hear that from my hon. Friend. It is good to know that we are on track to achieve our ambition to reduce the rates of stillbirth, neonatal and maternal deaths and perinatal brain injuries by 20% by 2020. Innovations such as those in Aberdeen have contributed to that work. It is important that our regional communities have access to specialist care of the kind my hon. Friend describes, and we hope to deliver more through the accelerated access pathway.
Innovative Treatments and Technologies — House of Commons, 2017-11-14
Topic: Health
Questions: Thank you, Mr Speaker. [Laughter.] It goes back a long way, and one day it will be no more.One of the innovative treatments that is being offered in my constituency that concerns me is the use of puberty blockers and hormone replacement therapy for children who identify as transgender. Does the Minister agree that an improvement would actually mean the restriction of such treatments for under-18s?
Jacqueline Doyle-Price (Conservative, Centre-right): My hon. Friend makes a serious point. Health is a devolved matter in Wales. The NHS in England has strict guidelines on the prescription of puberty-blocking and cross-sex hormones for youngsters. Such treatments may be prescribed only with the agreement of a specialist multidisciplinary team and after a very careful assessment of the individual. We keep a watching eye on these matters.
Innovative Treatments and Technologies — House of Commons, 2017-11-14
Topic: Health
Questions: Thank you, Mr Speaker. [Laughter.] It goes back a long way, and one day it will be no more.One of the innovative treatments that is being offered in my constituency that concerns me is the use of puberty blockers and hormone replacement therapy for children who identify as transgender. Does the Minister agree that an improvement would actually mean the restriction of such treatments for under-18s?
Jacqueline Doyle-Price (Conservative, Centre-right): I can confirm to the hon. Lady that we have offered mutual recognition. She is right to raise this important subject because it is obviously vital that we maintain safety throughout the NHS, and access to pharmaceuticals is part of that.
Musculoskeletal Services: Greenwich — House of Commons, 2017-11-14
Topic: Health
Questions: What discussions he has had with local commissioners on changes to the cost of the contract for musculoskeletal services in Greenwich; and if he will make a statement.
Stephen Charles Brine (Conservative, Centre-right): Ministers have held no such discussions. The procurement of local health services by means of competitive tendering is a matter for the local clinical commissioning group, rather than for Ministers. Greenwich clinical commissioning group is an independent statutory organisation and is responsible for commissioning services for local people in order to ensure the best possible clinical outcomes at the best value to the taxpayers, who are the hon. Gentleman’s constituents.
Musculoskeletal Services: Greenwich — House of Commons, 2017-11-14
Topic: Health
Questions: What discussions he has had with local commissioners on changes to the cost of the contract for musculoskeletal services in Greenwich; and if he will make a statement.
Stephen Charles Brine (Conservative, Centre-right): It is not a complacent answer; it is a factual one. That is an important point to make. The Circle contract has been uplifted by approximately £10 million because of the increases in tariff costs, as the hon. Gentleman rightly says. That increase would have been applied to any provider, not just Circle. I am sorry that he does not support the new MS services across his constituency. My understanding is that, previously, those services were delivered by a number of different providers, with a wide variation in clinical outcomes for his constituents, in costs of care and in-patient experience. This is a step forward.
Contaminated Blood Inquiry — House of Commons, 2017-11-14
Topic: Health
Jacqueline Doyle-Price (Conservative, Centre-right): After the Prime Minister announced an independent inquiry into infected blood, the Department of Health consulted on the form of that inquiry. The Cabinet Office updated the House on 3 November, stating that it would be a statutory inquiry under the Inquiries Act 2005, and that the Cabinet Office would be the sponsoring Department. The NHS Business Services Authority started administering the new English infected blood payments support scheme on 1 November.
Primodos — House of Commons, 2017-11-14
Topic: Health
Stephen Charles Brine (Conservative, Centre-right): This is an incredibly sensitive subject. The report of the expert working group on hormone pregnancy tests will be published tomorrow. There will be a written ministerial statement with a copy of the report. This follows a rigorous review of all the available data on this subject by a panel with expertise in the relevant fields of science and healthcare.
Primodos — House of Commons, 2017-11-14
Topic: Health
Stephen Charles Brine (Conservative, Centre-right): I thank the hon. Lady for her question. I am open to offers from any Select Committee. It would be premature to consider issues of liability before considering the strength of the evidence and seeing the report, which we will study carefully. The report will conclude whether there is a causal association between the use of HPDs such as Primodos and adverse outcomes of pregnancy. We look forward to seeing its outcomes and its recommendations.
Sustainability and Transformation Partnerships — House of Commons, 2017-11-14
Topic: Health
Philip Martin Dunne (Conservative, Centre-right): There is no fixed timetable for sustainability and transformation partnerships to become accountable care systems. Evolution from an STP into one or more ACSs is dependent on an STP demonstrating that it is working in a locally integrated health system. Both commissioners and providers, in partnership with local authorities, will need to choose to assume collective responsibility for resource and public health, and the criteria for that were set out in NHS England’s next steps in the "Five Year Forward View".
Dental Health Services — House of Commons, 2017-11-14
Topic: Health
Stephen Charles Brine (Conservative, Centre-right): NHS England has a duty to commission primary care dental services to meet local need, including for the most deprived groups. Nationally, access continues to grow with 1.9 million more patients seen between 2010 and 2016. The Starting Well programme, of which I am sure the hon. Lady is aware, will work to improve the oral health of children under the age of five in 13 high- needs areas. The dental contract reform programme is also working to improve access and oral health.
Dental Health Services — House of Commons, 2017-11-14
Topic: Health
Stephen Charles Brine (Conservative, Centre-right): I am interested to hear the hon. Lady say that, because the January to March 2017 GP patient survey results, which were published in July, show that 97% of those trying to get an NHS dental appointment in the Newcastle Gateshead clinical commissioning group area were successful, compared with the 95% England average.
Topical Questions — House of Commons, 2017-11-14
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): As well as congratulating the Minister for Public Health on being an excellent ambassador for the United Kingdom at the G7 health summit in Milan, I congratulate Colchester Hospital University NHS Foundation Trust on exiting special measures. It is the 21st trust to do so and was in special measures for longer than any other trust. The fact that it got a good rating for compassion, for the effectiveness of its care and for its leadership is a huge tribute to the hard work of staff.
Topical Questions — House of Commons, 2017-11-14
Topic: Health
Questions: Thank you, Mr Officer Dibble Speaker. In my constituency we have the outstanding-rated Worthing Hospital and some outstanding GP practices, but we also have the Sussex and East Surrey sustainability and transformation plan, which has been rated in category 4 —“needs most improvement”. Part of the problem is that it is too big and does not follow a natural footprint. Will the Minister support local calls for it to be withdrawn, and help to make it fit for purpose and sustainable?
Stephen Charles Brine (Conservative, Centre-right): Sustainability and transformation plan footprints were determined as a result of discussions between local areas, NHS England and NHS Improvement. They reflect a number of factors including patient flow, the location of different organisations in the local health economy and natural geographies. We stated in the next steps of the "Five Year Forward View" that adjusting STP boundaries is open to discussions between us and NHS England when that is collectively requested by local organisations, and we mean that.
Topical Questions — House of Commons, 2017-11-14
Topic: Health
Questions: Thank you, Mr Officer Dibble Speaker. In my constituency we have the outstanding-rated Worthing Hospital and some outstanding GP practices, but we also have the Sussex and East Surrey sustainability and transformation plan, which has been rated in category 4 —“needs most improvement”. Part of the problem is that it is too big and does not follow a natural footprint. Will the Minister support local calls for it to be withdrawn, and help to make it fit for purpose and sustainable?
Stephen Charles Brine (Conservative, Centre-right): The hon. Lady will have to wait for the Budget like everybody else. We continue to monitor the market carefully in the community pharmacies sector. Access to pharmaceutical services is very good in England, with 88% of people falling within a 20-minute walk of a community pharmacy. For areas with fewer pharmacies, our access scheme continues to provide additional protection, and a growing number of internet pharmacies also support access, offering patients greater choice. Pharmacies are a critical part of the primary care infrastructure in this country.
Engagements — House of Commons, 2020-09-30
Topic: Health
Keir Starmer (Labour, Centre-left): When local restrictions were introduced, the Prime Minister described them as a "whack-a-mole" strategy. That implies that at some stage the mole goes down and restrictions are lifted, but in fact, in some lockdown areas infection rates are still going up, and in towns such as Bradford, Bury and Oldham restrictions have now been in place for months. For many of those communities that are affected, things feel like they are getting worse, not better, so I ask a question on their behalf: what is the Prime Minister’s strategy for bringing these places out of restrictions so that they can see their families again?
Topical Questions — House of Commons, 2017-11-14
Topic: Health
Questions: Thank you, Mr Officer Dibble Speaker. In my constituency we have the outstanding-rated Worthing Hospital and some outstanding GP practices, but we also have the Sussex and East Surrey sustainability and transformation plan, which has been rated in category 4 —“needs most improvement”. Part of the problem is that it is too big and does not follow a natural footprint. Will the Minister support local calls for it to be withdrawn, and help to make it fit for purpose and sustainable?; A few months ago, Medway hospital came out of special measures, with the improvement to patient safety being one of the most notable highlights in the report. Given the success in my local area, will my right hon. Friend inform the House what progress he is making to boost patient safety across the rest of the country?; Could I raise the issue of mesh implants, which has been raised with me by constituents? A report in the United States indicates the associated pain—the headaches and the aches and pains in joints. Are Her Majesty’s Government looking at this issue? Rather than Ministers saying that this is merely a matter for the devolved Administrations, it would be instructive if they could give me an answer, because that would help inform the Scottish Government.
Jacqueline Doyle-Price (Conservative, Centre-right): The hon. Gentleman raises an issue that is of concern to many women up and down the country, and no one can fail to be moved by some of the horrendous injuries they experience. We now have 18 centres of specialist care that can treat those women. However, the advice we still receive is that, in some very narrow cases of stress incontinence, mesh remains the best possible treatment. The issue will be kept under review, and my noble Friend Lord O'Shaughnessy is due to meet the all-party group on surgical mesh implants to consider it in greater detail.
Topical Questions — House of Commons, 2017-11-14
Topic: Health
Questions: Thank you, Mr Officer Dibble Speaker. In my constituency we have the outstanding-rated Worthing Hospital and some outstanding GP practices, but we also have the Sussex and East Surrey sustainability and transformation plan, which has been rated in category 4 —“needs most improvement”. Part of the problem is that it is too big and does not follow a natural footprint. Will the Minister support local calls for it to be withdrawn, and help to make it fit for purpose and sustainable?; A few months ago, Medway hospital came out of special measures, with the improvement to patient safety being one of the most notable highlights in the report. Given the success in my local area, will my right hon. Friend inform the House what progress he is making to boost patient safety across the rest of the country?; Could I raise the issue of mesh implants, which has been raised with me by constituents? A report in the United States indicates the associated pain—the headaches and the aches and pains in joints. Are Her Majesty’s Government looking at this issue? Rather than Ministers saying that this is merely a matter for the devolved Administrations, it would be instructive if they could give me an answer, because that would help inform the Scottish Government.; The James Paget Hospital at Gorleston, which is doing great work under great pressure, has highlighted the fact that it and the clinical commissioning group have two different regulators. Does my right hon. Friend agree that it would be sensible for one body to oversee both organisations, so as to avoid duplication and redirect funds to the front line?
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): My hon. Friend makes an important point. We have no plans for legislative changes, but we do want to see closer working between NHS Improvement and NHS England on the ground, so that people working in constituencies and areas such as his get only one set of instructions. We are making good progress.
Topical Questions — House of Commons, 2017-11-14
Topic: Health
Questions: Thank you, Mr Officer Dibble Speaker. In my constituency we have the outstanding-rated Worthing Hospital and some outstanding GP practices, but we also have the Sussex and East Surrey sustainability and transformation plan, which has been rated in category 4 —“needs most improvement”. Part of the problem is that it is too big and does not follow a natural footprint. Will the Minister support local calls for it to be withdrawn, and help to make it fit for purpose and sustainable?; A few months ago, Medway hospital came out of special measures, with the improvement to patient safety being one of the most notable highlights in the report. Given the success in my local area, will my right hon. Friend inform the House what progress he is making to boost patient safety across the rest of the country?; Could I raise the issue of mesh implants, which has been raised with me by constituents? A report in the United States indicates the associated pain—the headaches and the aches and pains in joints. Are Her Majesty’s Government looking at this issue? Rather than Ministers saying that this is merely a matter for the devolved Administrations, it would be instructive if they could give me an answer, because that would help inform the Scottish Government.; The James Paget Hospital at Gorleston, which is doing great work under great pressure, has highlighted the fact that it and the clinical commissioning group have two different regulators. Does my right hon. Friend agree that it would be sensible for one body to oversee both organisations, so as to avoid duplication and redirect funds to the front line?; I have repeatedly asked the Secretary of State, and I ask him yet again, whether he will visit my area to see for himself the damaging impacts that the downgrades and closures of local hospital services in Dewsbury and Huddersfield will have on my constituents.
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): I am very happy to accept the hon. Lady’s invitation to visit her area, which I will do, but what I know I will see when I go there is that 8,300 more people are being treated within four hours at her local hospital, where there are 42 more doctors and 56 more nurses than in 2010.
Engagements — House of Commons, 2020-09-30
Topic: Health
Deborah Angela Elspeth Marie Abrahams (Labour, Centre-left): With over 7,000 new cases and 71 deaths from covid yesterday, and a seven-day case average of 183 per 100,000 in Oldham, will the Prime Minister tell my constituents what he thinks his biggest mistake has been to date? Is it locking down too late, or lifting the lockdown without a fully operational test, track and isolate system? Is it the billions wasted in backroom deals with the private sector on personal protective equipment that does not fit, on test and trace that does not work, and more? Or is it all of the above?
Coronavirus Act 2020 (Review of Temporary Provisions) — House of Commons, 2020-09-30
Topic: Health
Nicklaus Thomas-Symonds (Labour, Centre-left): I am grateful for the opportunity to speak in this debate, having taken the Bill through its Committee stages back in March We come to the House today to debate the renewal of the provisions of the Coronavirus Act, in the gravest of circumstances. Here in the United Kingdom, we have seen over 42,000 deaths, lives altered in ways unimaginable a year ago, and our economy facing one of the worst recessions on record. We accept the challenge that presents, which is why we have recognised that, in a pandemic, any Government need extraordinary powers available, and why, with a heavy heart, facing this highly unsatisfactory situation of an all-or-nothing motion, we will not block its passage We have supported the Government when it has been right to do so, and the British people, who have sacrificed so much in the national effort to address this virus, deserve nothing less. But today we say to the Government that things cannot go on as they are. The incredible efforts of the British people have not been matched with competence and grip by the UK Government. Announcements about measures have been made overnight, with no proper notice and no proper power of review, and Government Ministers have appeared on national media with absolutely no idea of what the rules are. The public are being let down on a grand scale The Government have had virtually all the resources and brilliance of our remarkable country on demand for over six months. They have been able to call on the UK’s remarkable frontline workers, who have shown incredible skill and bravery through this crisis. Yet we have ended up with one of the highest death rates in the world and on the threshold of one of the deepest recessions At the same time, the road ahead is anything but clear. Our testing system is inadequate, at the very moment we need it most, and this is having a devastating impact. Losing control of testing means losing control of the virus. It is that loss of control that makes further restrictions necessary. It is restrictions that are having a devastating effect on families and businesses up and down the country. This dire situation was not inevitable. It is the result of a chronic failure of Government. Today we must take stock of where we are and the urgent need for the Government to get a grip.
Coronavirus Act 2020 (Review of Temporary Provisions) — House of Commons, 2020-09-30
Topic: Health
Nicklaus Thomas-Symonds (Labour, Centre-left): My right hon. Friend is absolutely right. The UK Government need to get a grip and work with the other Governments and local councils around the United Kingdom on an equal basis Right at the start of the pandemic, the World Health Organisation said that we should "test, test, test", and it was clear that that would be a vital element in regaining any form of normality. The Government had the country’s full resources on hand, and on 20 May the Prime Minister promised a "world-beating" test, track and isolate system by 1 June. I am not asking for a world-beating system; an effective one would do just fine. But shamefully, this has not been achieved all these months later. Is not this the problem with the Prime Minister? He always promises a better tomorrow, but he never delivers today.